Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genoil (GNOLF) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to 1811.75%.

  • Genoil's EBITDA Margin rose 1740900.0% to 1811.75% in Q3 2025 from the same period last year, while for Sep 2025 it was 6629.06%, marking a year-over-year increase of 65052200.0%. This contributed to the annual value of 975.09% for FY2019, which is 14528300.0% up from last year.
  • As of Q3 2025, Genoil's EBITDA Margin stood at 1811.75%, which was up 1740900.0% from 2745.78% recorded in Q2 2025.
  • In the past 5 years, Genoil's EBITDA Margin ranged from a high of 2846.68% in Q4 2024 and a low of 3571.28% during Q3 2023
  • Moreover, its 5-year median value for EBITDA Margin was 97.92% (2021), whereas its average is 818.42%.
  • As far as peak fluctuations go, Genoil's EBITDA Margin crashed by -35136400bps in 2023, and later skyrocketed by 27593100bps in 2024.
  • Genoil's EBITDA Margin (Quarter) stood at 5.08% in 2021, then rose by 9bps to 5.53% in 2022, then skyrocketed by 1481bps to 87.37% in 2023, then skyrocketed by 3158bps to 2846.68% in 2024, then plummeted by -164bps to 1811.75% in 2025.
  • Its EBITDA Margin stands at 1811.75% for Q3 2025, versus 2745.78% for Q2 2025 and 1970.42% for Q1 2025.